Basal cell carcinoma is a kind of skin cancer that most commonly occurs on sun-exposed parts of skin, such as the face. Basal cell carcinoma appears as a brown or glossy black lump with a rolled border on brown and black skin. Skin cancer is known as basal cell carcinoma.
The majority of basal cell and squamous cell skin cancers are generated by frequent and unprotected skin exposure to ultraviolet (UV) radiation from sunlight as well as from man-made sources such as tanning beds. UV radiation can cause DNA damage inside skin cells.
These are the most common signs and symptoms of this disease:
Basal cell carcinoma is most often treated with surgery to remove all of cancer and some of the healthy tissue around it. Options might include Surgical excision. In this procedure, the specialist surgeon/dermatologist cuts out the cancerous lesion and a surrounding margin of healthy skin.
What is worth noting in this respect is that surgical procedures are getting less and less popular as laser surgery takes their place as a safer, faster, and bloodless kind of surgery.
In laser surgeries, the dermatologist directs a beam of intense light at the tumor to targeting superficial BCCs. Some lasers vaporize (ablate) the skin cancer while others (nonablative lasers) convert the beam of light to heat, which destroys the tumor without injuring the surface of the skin.
To perfectly accomplish this sensitive excision task, a proper and highly professional laser machine is needed.
In this vein, the Portable Surgery 810nm Diode Laser System FDA LASER-1.2A is one of the most recommended equipment among surgeons due to its excellent efficacy in treating such forms of cancer.
This device’s blue laser light interacts better with the tissue components haemoglobin or melanin. At 980 nm, the machine performs better and gentler cutting, even at lower power.
As such, its improved cutting performance makes it ideally suited to all surgical applications, particularly for Basal Cell Skin cancer.
What also makes the LASER-1.2A highly recommended by surgeons is that it displays an accurate alignment and exact sighting during the treatment. All thanks to its green aiming beam.
To further improve the treatment, the device is supported with a fibre guide laser. So, it is compatible with various endoscopic uses. Also, these special fibres are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.
With 980 nm wavelength and 15W as maximum power, the device is thought to perfectly suit Basal Cell Skin cancer highly-sensitive surgeries.
That is highly attributed to the fact that The LASER-1.2 A uses infrared wavelengths and ultra-blue light to ensure high-level performance.
That is also estimated to reduce thermal damage and its peculiar interaction with haemoglobin.
Due to all these features, the LASER-1.2 A guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.
Since their invention, laser use and applications have expanded rapidly as it proved to be a successful addition to cancer surgery.
In this article, we discuss the benefits of laser therapy and precisely the efficacy of LASER-1.2 A as a surgical laser device capable of efficiently treating Basal Cell Skin cancer.
Reference: Basal Cell Carcinoma Treatment
Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFLASER is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.
The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.